quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:12·137d
SECFiling
Cassava Sciences Inc. logo

SEC Form EFFECT filed by Cassava Sciences Inc.

SAVA· Cassava Sciences Inc.
Health Care
Original source

Companies

  • SAVA
    Cassava Sciences Inc.
    Health Care

Recent analyst ratings

  • Nov 26UpdateH.C. Wainwright-
  • Oct 8UpdateH.C. Wainwright$116.00
  • Jul 1UpdateH.C. Wainwright-
  • Nov 16UpdateB. Riley Securities$44.00
  • Jan 24UpdateB. Riley Securities$72.00
  • Jul 20UpdateHC Wainwright & Co.$124.00

Related

  • SEC42d
    SEC Form 10-K filed by Cassava Sciences Inc.
  • SEC42d
    Cassava Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC44d
    Cassava Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR44d
    Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
  • SEC63d
    Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • PR63d
    Cassava Announces Closure of U.S. Department of Justice Investigation
  • PR100d
    Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer's Disease in the Journal of Prevention of Alzheimer's Disease
  • SEC121d
    Cassava Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022